Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs Google Inc (GOOG) Price & Performance

Amgen, Inc.Trade
Google IncTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs Google Inc — how do they compare? Amgen, Inc. trades at $360.83 (market cap $196.12B), while Google Inc trades at $350.59 (market cap $4.35T). The key difference: Google Inc is far larger — about 22.2× Amgen, Inc.'s market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.

AMGNGOOG
Market Cap
$196.12B$4.35T
Sector
HealthTechnology
52-Week High
$388.16$399.06
52-Week Low
$271.18$181.31
Enterprise Value
$241.41B$4.31T
Dividend Yield
2.77%0.25%
Volume
1,511,127

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG